Accue Life Science Industries Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 4 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 50.90%
(FY 2022)
- Ebitda 833.37%
(FY 2022)
- Net Worth -114.56%
(FY 2022)
- Total Assets 20.50%
(FY 2022)
About Accue Life Science Industries
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arvindkumar Singh and Meenakshi Singh serve as directors at the Company.
- CIN/LLPIN
U24290GJ2020PTC118555
- Company No.
118555
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2020
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Accue Life Science Industries?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvindkumar Singh  | Director | 24-Aug-2024 | Current |
| Meenakshi Singh | Whole-Time Director | 01-Dec-2020 | Current |
Financial Performance of Accue Life Science Industries.
Accue Life Science Industries Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 50.9% increase in profit. The company's net worth observed a substantial decline by a decrease of 114.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accue Life Science Industries?
Unlock access to Accue Life Science Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Acna Dye Chem P.Ltd.Active 31 years 2 monthsArvindkumar Singh and Meenakshi Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Accue Life Science Industries?
Accue Life Science Industries has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accue Life Science Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accue Life Science Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
